Adriana Zeevi

Q: What Schools Are Affiliated With Adriana Zeevi

Adriana Zeevi is affiliated with the following schools: University of California, Berkeley, Stanford University, University of Pittsburgh

Adriana Zeevi's AcademicInfluence.com Rankings

Adriana Zeevi

Computer Science

#6901

World Rank

#7268

Historical Rank

Computational Linguistics

#1288

World Rank

#1302

Historical Rank

Machine Learning

#2385

World Rank

#2415

Historical Rank

Artificial Intelligence

#2669

World Rank

#2710

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Adriana Zeevi's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Adriana Zeevi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Adriana Zeevi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. (2005) (1303)
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. (2005) (1223)
Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (2010) (751)
Complement-binding anti-HLA antibodies and kidney-allograft survival. (2013) (738)
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation (2013) (687)
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology (2016) (509)
National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation (2004) (470)
Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. (1995) (427)
Systemic chimerism in human female recipients of male livers (1992) (374)
CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION (1993) (337)
Baboon-to-human liver transplantation (1993) (331)
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection (2016) (330)
Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay (2006) (329)
Five Hundred Intestinal and Multivisceral Transplantations at a Single Center: Major Advances With New Challenges (2009) (327)
Report from a consensus conference on antibody-mediated rejection in heart transplantation. (2011) (324)
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection (2020) (283)
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation (1994) (278)
Acute antibody-mediated rejection of cardiac transplants. (2006) (276)
Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms (2003) (273)
Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. (2016) (257)
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management (2003) (251)
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. (2016) (239)
A randomized trial of inhaled cyclosporine in lung-transplant recipients. (2006) (207)
Voriconazole Prophylaxis in Lung Transplant Recipients (2006) (199)
Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. (2015) (195)
Statin use is associated with improved function and survival of lung allografts. (2003) (191)
Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. (2013) (184)
Upper-Extremity Transplantation Using a Cell-Based Protocol to Minimize Immunosuppression (2013) (184)
Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA (2013) (184)
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report (2018) (180)
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. (2005) (176)
Heart-lung transplantation: lessons learned and future hopes. (1987) (175)
Dendritic Cell Subset Ratio in Peripheral Blood Correlates with Successful Withdrawal of Immunosuppression in Liver Transplant Patients (2003) (161)
Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. (2008) (154)
HLA‐Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction (2005) (152)
Preformed and De Novo Donor Specific Antibodies in Visceral Transplantation: Long‐Term Outcome With Special Reference to the Liver (2012) (152)
Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients (1995) (150)
Report from a consensus conference on the sensitized patient awaiting heart transplantation. (2009) (149)
Contribution of Naïve and Memory T‐Cell Populations to the Human Alloimmune Response (2009) (147)
Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus (2004) (145)
Tacrolimus Dosing in Adult Lung Transplant Patients Is Related to Cytochrome P4503A5 Gene Polymorphism (2004) (140)
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. (2004) (135)
HLA Mismatching Increases the Risk of BK Virus Nephropathy in Renal Transplant Recipients (2004) (124)
Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. (2003) (120)
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. (2014) (119)
Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. (2003) (119)
A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients (2015) (118)
Aerosolized cyclosporine in lung recipients with refractory chronic rejection. (1996) (115)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS (1995) (114)
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. (2005) (111)
IMPDH1 Gene Polymorphisms and Association With Acute Rejection in Renal Transplant Patients (2008) (110)
Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance (2009) (109)
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. (1997) (107)
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. (2005) (107)
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. (2017) (106)
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. (2002) (106)
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. (1997) (105)
Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? (1991) (103)
Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent Weaning (2003) (102)
Dendritic Cell Subset Ratio in Tolerant, Weaning and Non‐Tolerant Liver Recipients Is Not Affected by Extent of Immunosuppression (2004) (101)
C1 Inhibitor in Acute Antibody‐Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study (2016) (101)
Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. (1988) (99)
Immunologically Mediated Disease of the Airways after Pulmonary Transplantation (1988) (97)
Frequent achievement of a drug-free state after orthotopic liver transplantation. (1993) (96)
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients (2015) (95)
Allosensitized humans are at no greater risk of humoral rejection of GT‐KO pig organs than other humans (2006) (93)
The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. (2001) (92)
Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. (2008) (91)
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. (2017) (87)
Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection (2009) (85)
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. (1997) (84)
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. (1987) (83)
Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation (1994) (82)
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. (2001) (79)
Survival in allosensitized children after listing for cardiac transplantation. (2007) (79)
C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. (2005) (78)
Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver Transplantation (2008) (78)
The epidemiology of parainfluenza virus infection in lung transplant recipients. (2001) (77)
Disparate Distribution of 16 Candidate Single Nucleotide Polymorphisms Among Racial and Ethnic Groups of Pediatric Heart Transplant Patients (2006) (77)
Dose-related reversal of acute lung rejection by aerosolized cyclosporine. (1997) (76)
Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High‐Resolution Rather Than the Antigen Level? (2015) (75)
TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. (1996) (74)
Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. (1984) (74)
Anti-HLA antibody analysis and crossmatching in heart and lung transplantation. (2004) (73)
Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis (2018) (71)
Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. (2006) (70)
Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. (1990) (69)
Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors. (2006) (68)
Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA‐Drilling Down on Key Sources of Variation (2013) (68)
Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. (1997) (67)
A novel variant L263F in human inosine 5′-monophosphate dehydrogenase 2 is associated with diminished enzyme activity (2007) (66)
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. (1986) (66)
Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. (1997) (65)
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans (2004) (63)
Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays. (2013) (63)
Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. (2019) (63)
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. (1986) (62)
Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. (2005) (60)
Re‐examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? (2012) (60)
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. (2006) (60)
Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients. (2010) (59)
Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes (1991) (59)
Recovery of Functional Memory T Cells in Lung Transplant Recipients Following Induction Therapy with Alemtuzumab (2007) (58)
Genetic Polymorphisms Impact the Risk of Acute Rejection in Pediatric Heart Transplantation: A Multi-Institutional Study (2008) (58)
HLA-G Level on Monocytoid Dendritic Cells Correlates With Regulatory T-Cell Foxp3 Expression in Liver Transplant Tolerance (2011) (58)
Two Hundred Living Donor Kidney Transplantations Under Alemtuzumab Induction and Tacrolimus Monotherapy: 3‐Year Follow‐Up (2009) (57)
Acute Humoral Rejection of Human Lung Allografts and Elevation of C4d in Bronchoalveolar Lavage Fluid (2004) (53)
The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. (2005) (52)
PULMONARY ARTERIOSCLEROSIS IN LONG‐TERM HUMAN HEART‐LUNG TRANSPLANT RECIPIENTS (1989) (52)
Proteasome Inhibitor Carfilzomib‐Based Therapy for Antibody‐Mediated Rejection of the Pulmonary Allograft: Use and Short‐Term Findings (2017) (52)
Real-time monitoring of acute liver-allograft rejection using the Banff schema. (2002) (50)
HLA-class II antigen expression in human heart-lung allografts. (1990) (50)
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. (1995) (49)
The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis (2011) (49)
The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody‐Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions (2016) (49)
Immunologic Challenges in Small Bowel Transplantation (2012) (49)
A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome (2017) (48)
The Histopathology of Lung Allograft Dysfunction Associated With the Development of Donor-specific HLA Alloantibodies (2012) (48)
Real-time monitoring of acute liver-allograft rejection using the Banff schema1 (2002) (48)
Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. (2009) (48)
Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney (2008) (48)
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. (1991) (48)
Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. (2008) (47)
Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes (2017) (46)
Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. (2006) (46)
Combined simultaneous kidney/bone marrow transplantation. (1995) (46)
A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies (2010) (46)
Alemtuzumab Pre‐Conditioning With Tacrolimus Monotherapy in Pediatric Renal Transplantation (2007) (46)
Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation. (1995) (46)
ABO-compatible liver allograft antibody-mediated rejection: an update (2015) (45)
Cytokine Profiles in a Rat Model of Otitis Media With Effusion Caused by Eustachian Tube Obstruction With and Without Streptococcus pneumoniae Infection (2002) (45)
A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation. (2015) (45)
Effects of donor bone marrow infusion in clinical lung transplantation. (2000) (45)
Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. (1995) (45)
Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-&ggr; Inhibition in CD8− and CD8+ Peripheral Blood T Cells (2001) (45)
Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. (1983) (44)
Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. (2005) (44)
Short‐term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol (2018) (44)
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. (2007) (44)
Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. (2002) (43)
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. (2005) (43)
Interleukin-6, a marker of preservation injury in clinical lung transplantation. (1992) (43)
Long-Term Effects of Alemtuzumab on Regulatory and Memory T-Cell Subsets in Kidney Transplantation (2012) (43)
Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study (2013) (42)
Infusion of donor leukocytes to induce tolerance in organ allograft recipients (1999) (42)
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. (2001) (42)
Heart and lung transplantation in children (2006) (42)
Lung Deposition and Pharmacokinetics of Cyclosporine After Aerosolization in Lung Transplant Patients (2003) (42)
Pediatric Intestinal Retransplantation: Techniques, Management, and Outcomes (2008) (42)
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. (1985) (41)
Pancreas Transplantation Under Alemtuzumab (Campath-1H) and Tacrolimus: Correlation Between Low T-Cell Responses and Infection (2006) (41)
Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches. (2010) (41)
Upregulation of Messenger RNA for Inflammatory Cytokines in Middle Ear Mucosa in a Rat Model of Acute Otitis Media (1998) (40)
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. (1995) (40)
Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection. (2008) (40)
Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. (1995) (40)
Alemtuzumab Preconditioning With Tacrolimus Monotherapy—The Impact of Serial Monitoring for Donor-Specific Antibody (2008) (40)
Fatal transfusion‐associated graft‐versus‐host disease in an immunocompetent recipient of a volunteer unit of red cells (2006) (39)
Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders (1999) (38)
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. (2000) (38)
Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. (2010) (38)
Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28- T-suppressor cells. (2005) (38)
P‐glycoprotein (P‐gp) Is Upregulated in Peripheral T‐Cell Subsets from Solid Organ Transplant Recipients (2001) (37)
Preservation of post-transplant lung function with aerosol cyclosporin (2004) (37)
Excretion of cyclosporine and its metabolites in human bile. (1986) (37)
Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factors. (1977) (37)
Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults. (2003) (37)
Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. (1990) (37)
Early tolerance in pediatric liver allograft recipients. (1994) (36)
Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients. (1997) (36)
Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody‐mediated rejection (AMR) (2018) (36)
Cytokine Induction During Cardiac Surgery: Analysis of TNF‐α Expression Pre‐and Postcardiopulmonary Bypass (1995) (36)
Tumor Necrosis Factor–α Promoter Gene Polymorphism ‐308 and Chorioamnionitis (2003) (35)
Propagation and characterization of lymphocytes from transplant biopsies. (1991) (35)
Anti‐HLA alloantibodies in pediatric solid organ transplantation (2006) (35)
Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence. (2019) (35)
Acute Renal Allograft Rejection: Diagnostic Significance of Focal Peritubular Capillary C4d (2008) (35)
Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. (1993) (34)
Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation. (2004) (34)
Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. (1998) (34)
A polymorphism linked to elevated levels of interferon-γ is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center. (2011) (34)
Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. (1993) (34)
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. (1988) (33)
Mixed allogeneic chimerism in lung allograft recipients. (1994) (33)
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. (1991) (33)
Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts. (2007) (32)
HLA phenotype of lung lavage cells following heart-lung transplantation. (1985) (32)
Alloreactivity of lung biopsy and bronchoalveolar lavage-derived lymphocytes from pulmonary transplant patients: correlation with acute rejection and bronchiolitis obliterans (1990) (32)
Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection. (2018) (31)
Amnion-Derived Multipotent Progenitor Cells Inhibit Blood Monocyte Differentiation into Mature Dendritic Cells (2014) (31)
Diminished IL-10 production in subjects with allergy after infection with influenza A virus. (1999) (31)
Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors (2018) (31)
FK 506 as a growth control factor. (1990) (30)
EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. (2005) (30)
Delayed onset CMV disease in solid organ transplant recipients. (2009) (30)
The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis. (2004) (30)
Immune status of recipients following bone marrow-augmented solid organ transplantation. (1995) (30)
Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. (1991) (29)
Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children (2017) (29)
Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients (2018) (29)
Plasma Inflammatory Mediators Associated with Bone Metabolism in COPD (2010) (29)
EX VIVO GENERATION OF EFFECTIVE EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES FROM THE PERIPHERAL BLOOD OF IMMUNOCOMPETENT EPSTEIN BARR VIRUS-SERONEGATIVE INDIVIDUALS1 (2000) (29)
Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. (2012) (29)
Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts (1986) (29)
Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection (2016) (29)
Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. (1998) (29)
How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402? (2009) (28)
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia (2011) (28)
Ex Vivo Priming of Naïve T Cells Into EBV‐Specific Th1/Tc1 Effector Cells by Mature Autologous DC Loaded with Apoptotic/Necrotic LCL (2003) (28)
Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. (1996) (28)
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. (1995) (28)
Regulation of constitutive nitric oxide synthase activity by the human heart. (1995) (28)
Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. (2008) (28)
Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation. (1997) (27)
HLA antibody analysis (2006) (27)
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. (1985) (26)
EDTA Treatment of Serum Unmasks Complement-Mediated Prozone Inhibition in Human Leukocyte Antigen Antibody Testing. (2016) (26)
Immunogenetic analysis of the HLA complex with alloreactive T cell clones. (1983) (25)
From Humoral Theory to Performant Risk Stratification in Kidney Transplantation (2017) (25)
In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. (2000) (25)
Clinical significance of CMV-specific T helper responses in lung transplant recipients. (1998) (25)
Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. (1994) (25)
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. (1996) (25)
Anti-Human Leukocyte Antigen Antibodies, Vascular C4d Deposition and Increased Soluble C4d in Broncho-Alveolar Lavage of Lung Allografts (2008) (25)
HLA antigen expression on cultured human arterial endothelial cells. (1988) (25)
The Impact of EBV Load on T-Cell Immunity in Pediatric Thoracic Transplant Recipients (2009) (24)
Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells (2017) (24)
Allospecific CD154 + T‐cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation (2012) (24)
Early subclinical tubulitis and interstitial inflammation in kidney transplantation have adverse clinical implications. (2020) (24)
The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy (2009) (24)
Detection of non-HLA-DR determinants by alloreactive lymphocyte clones. (1983) (24)
Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition. (1990) (24)
Immunodiagnostics: Evaluation of Functional T-Cell Immunocompetence in Whole Blood Independent of Circulating Cell Numbers (2007) (24)
Simkania Negevensis in Bronchoalveolar Lavage of Lung Transplant Recipients: A Possible Association with Acute Rejection (2007) (24)
P-GLYCOPROTEIN ACTIVITY IS DECREASED IN CD4+ BUT NOT CD8+ LUNG ALLOGRAFT-INFILTRATING T CELLS DURING ACUTE CELLULAR REJECTION (2004) (23)
Elevated Myeloid: Plasmacytoid Dendritic Cell Ratio Associates With Late, but Not Early, Liver Rejection in Children Induced With Rabbit Anti-Human Thymocyte Globulin (2009) (23)
Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. (1991) (23)
DENDRITIC CELL SUBSET RATIO IN TOLERANT, WEANING, AND NON-TOLERANT LIVER RECIPIENTS IS NOT AFFECTED BY EXTENT OF IMMUNOSUPPRESSION (2004) (23)
Allospecific CD154+ B Cells Associate With Intestine Allograft Rejection in Children (2010) (23)
High‐Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms (2015) (23)
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. (1994) (23)
Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC‐04 multi‐institutional study (2018) (22)
Lymphocyte activation in bronchoalveolar lavages from heart-lung transplant recipients. (1988) (22)
Enhanced Donor‐Specific Alloreactivity Occurs Independently of Immunosuppression in Children with Early Liver Rejection (2005) (22)
RARE-EVENT ANALYSIS OF CIRCULATING HUMAN DENDRITIC CELL SUBSETS AND THEIR PRESUMPTIVE MOUSE COUNTERPARTS1 (2001) (22)
Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant (2018) (22)
Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation (2017) (22)
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. (1988) (21)
The Influence of Race and Common Genetic Variations on Outcomes After Pediatric Heart Transplantation (2017) (21)
Elevated Myeloid: Plasmacytoid Dendritic Cell Ratio Associates With Early Acute Cellular Rejection in Pediatric Small Bowel Transplantation (2010) (21)
Unopposed neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis. (1999) (21)
Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection. (2011) (21)
Increased lung allograft failure in patients with HLA-specific antibody. (2007) (21)
Impact of TGFβ1 gene polymorphisms on late renal function in pediatric heart transplantation (2005) (21)
Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation. (2008) (21)
Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system. (1982) (21)
Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. (2020) (21)
FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. (1987) (21)
Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. (2009) (21)
Association between TNF-α and TGF-β genotypes in infants and parental history of allergic rhinitis and asthma (2004) (21)
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. (1990) (20)
DOMINANCE OF HIGH-PRODUCING INTERLEUKIN 6 AND LOW-PRODUCING INTERLEUKIN 10 AND INTERFERON γ ALLELES IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE- DEFICIENT TRAUMA PATIENTS (2005) (20)
Gene Polymorphisms Impact the Risk of Rejection With Hemodynamic Compromise: A Multicenter Study (2011) (20)
Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells. (1994) (20)
Sensitivity, Specificity, and Clinical Significance in Solid Organ Transplantation (2006) (20)
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. (1997) (20)
Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. (1988) (20)
Incidence, characterization, and impact of newly detected donor‐specific anti‐HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC‐04 study (2018) (20)
DQ α and β RFLP reveals the composition of the DQ molecule recognized by T-cell clones (2004) (19)
Donor‐derived regulatory dendritic cell infusion results in host cell cross‐dressing and T cell subset changes in prospective living donor liver transplant recipients (2020) (19)
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. (1997) (19)
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. (1990) (19)
Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation. (1990) (19)
T‐Lymphocyte Colony Growth in vitro: Factors Modulating Clonal Expansion (1981) (19)
Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection. (1989) (19)
Cylex ImmuKnow Cell Function Assay. (2013) (19)
Impact of TGFβ1 Gene Polymorphisms on Acute and Chronic Rejection in Pediatric Heart Transplant Allografts (2006) (18)
Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants. (1983) (18)
Immunologic consequences of transplantation. (1995) (18)
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. (2003) (18)
Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow (1994) (18)
Analysis of T lymphocytes infiltrating human hepatic allografts. (1987) (18)
Functional differences between cells from MLR colonies grown in soft agar cultures. (1980) (18)
Antibody-mediated rejection in lung transplantation: case reports. (2006) (18)
Tumor necrosis factor-alpha promoter gene polymorphism -308 and chorioamnionitis. (2003) (18)
Multivisceral intestinal transplantation: surgical pathology. (1989) (18)
HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen. (2009) (18)
Inosine 5′‐monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients (2010) (18)
PROLIFERATION OF CYTOMEGALOVIRUS‐PRIMED LYMPHOCYTES IN BRONCHOALVEOLAR LAVAGES FROM LUNG TRANSPLANT PATIENTS (1992) (17)
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. (2007) (17)
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. (2020) (17)
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. (1997) (17)
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. (1990) (17)
Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2. (2014) (17)
Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. (1997) (17)
Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children. (2007) (16)
Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. (1987) (16)
Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection. (1990) (16)
Gene expression profiles of early pneumococcal otitis media in the rat. (2005) (16)
Long-term culture of viable human pancreatic islets in pyruvate-rich medium. (1995) (16)
Persistent lack of human herpesvirus‐6 specific T‐helper cell response in liver transplant recipients (2002) (16)
Profile of the Pleximmune blood test for transplant rejection risk prediction (2016) (16)
Heterogeneity of cytolytic and suppressor clones of alloactivated cells generated from soft agar colonies. (1982) (16)
Pharmacogenomics and lung transplantation: clinical implications (2006) (16)
ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC molecules. (1986) (16)
Persistent lack of human herpesvirus‐6 specific T‐helper cell response in liver transplant recipients (2002) (16)
Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. (1989) (15)
Delayed Onset CMV Disease in Solid Organ Transplant Recipients (2009) (15)
Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. (1990) (15)
Molecular testing and prediction of clinical outcome in heart transplantation: a prospective multicenter trial (2004) (15)
Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges? (2017) (15)
Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation (2018) (14)
Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. (2000) (14)
The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis (2004) (14)
Association between TNF-alpha and TGF-beta genotypes in infants and parental history of allergic rhinitis and asthma. (2004) (14)
Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis (1998) (14)
Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants (2004) (14)
Antithymocyte Globulin Facilitates Alloreactive T-cell Apoptosis by Means of Caspase-3: Potential Implications for Monitoring Rejection-Free Outcomes (2015) (14)
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. (1993) (13)
Augmentation of Type-1 Polarizing Ability of Monocyte-Derived Dendritic Cells from Chronically Immunosuppressed Organ-Transplant Recipients (2005) (13)
Sequential Analysis of Tacrolimus Dosing in Adult Lung Transplant Patients With ABCB1 Haplotypes (2005) (13)
Immune monitoring in small bowel transplantation (2010) (13)
Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation (2017) (13)
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. (1991) (13)
MITOGEN RESPONSES OF LYMPHOCYTES FROM LUNG TRANSPLANT RECIPIENTS—CORRELATION WITH REJECTION AND INFECTION (1992) (13)
Effect of aminoguanidine and cyclosporine on lung allograft rejection. (1996) (13)
Renal transplantation at the University of Pittsburgh: the impact of FK506. (1994) (13)
Cytokine profile in graft-versus-host disease after small bowel transplantation. (1996) (13)
Adjuvant bone marrow infusion in clinical organ transplant recipients. (1998) (12)
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. (1998) (12)
Combined bone marrow and whole organ transplantation from the same donor. (1994) (12)
Impact of TGFbeta1 gene polymorphisms on late renal function in pediatric heart transplantation. (2005) (12)
Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients. (1987) (12)
Renal function and genetic polymorphisms in pediatric heart transplant recipients. (2012) (12)
Induction of graft acceptance after dog kidney or liver transplantation. (1990) (11)
Association of genetic polymorphisms and risk of late post-transplantation infection in pediatric heart recipients. (2010) (11)
Interactions between endothelial cells and alloreactive T cells involved in allograft immunity. (1988) (11)
Effect of 10 Pharmacologic Probes on mRNA Levels of Inducible Nitric Oxide Synthetase and Selected Inflammatory Cytokines in a Rat Model of Acute Otitis Media (2002) (11)
Clinical Significance of Cytomegalovirus-Specific T Helper Responses and Cytokine Production in Lung Transplant Recipients (2000) (11)
Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation. (1995) (11)
Cyclosporine Metabolites in Human Bile: Recovery and Immunologic Activity (1988) (11)
Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). (2019) (11)
Simultaneous solid organ, bone marrow, and islet allotransplantation in type I diabetic patients. (1994) (11)
Genotypic Variation and Phenotypic Characterization of Granzyme B Gene Polymorphisms (2009) (11)
Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. (1991) (11)
Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection. (1990) (11)
Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates. (2021) (11)
Prediction of rejection in lung transplantation. (2001) (11)
In vitro assessment of FK 506 immunosuppressive activity in transplant patients. (1991) (10)
Interleukin‐10 production by a B‐cell line derived from human post‐transplant lymphoproliferative disease (1995) (10)
Kidney transplantation with bone marrow augmentation: five-year outcomes. (2001) (10)
Measurement of basal, substrate induced and total P‐glycoprotein activity in bronchoalveolar lavage T‐cell subsets (2004) (10)
Monitoring the patient off immunosuppression (2001) (10)
IMPDH 1 Gene Polymorphisms and Association With Acute Rejection in Renal Transplant Patients (2008) (10)
T-bet+CD27+CD21– B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants (2021) (10)
Propagation and characterization of lymphocytes infiltrating livers of patients with primary biliary cirrhosis and autoimmune hepatitis. (1990) (9)
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. (1991) (9)
Dynamics of bronchoalveolar lavage in the canine lung transplant. (1988) (9)
Alloreactive T-cell recognition of two DQ beta allelic specificities associated with DQw1. (1987) (9)
Improved long-term culture of functional human islets in serum-free medium. (1994) (9)
HLA antibody profiling in thoracic transplantation undergoing desensitization therapy (2012) (9)
In vitro culture of B-lymphocytes derived from epstein-barr-virus-associated posttransplant lymphoproliferative disease: Cytokine production and effect of interferon-alpha (1997) (9)
Early findings after integration of donor‐derived cell‐free DNA into clinical care following pediatric heart transplantation (2021) (9)
Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. (1995) (9)
Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination (2021) (9)
NATURAL HISTORY OF EPSTEIN-BARR VIRUS LOAD IN PEDIATRIC THORACIC RECIPIENTS WITH POST TRANSPLANT LYMPHOPRO-LIFERATIVE DISORDERS AND OTHER PRIMARY EBV INFECTIONS (1999) (8)
Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation. (2013) (8)
Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression. (1991) (8)
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. (1987) (8)
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. (2011) (8)
Polymorphisms in cytokine genes do not predict progression to end-stage heart failure in children (2002) (8)
Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis (1992) (8)
Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. (1988) (8)
DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones. (1986) (8)
Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation (2006) (8)
DR4 and DQw3: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop (1989) (7)
Human-to-baboon bone marrow transplantation after conditioning with nonlethal irradiation. (1994) (7)
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. (1988) (7)
T‐helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections (2004) (7)
Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States. (2021) (7)
Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF). (1978) (7)
CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. (2006) (7)
In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. (1991) (7)
Perioperative donor bone marrow infusion in recipients of organ allografts. (1997) (7)
Colony Growth of T Lymphocytes in vitro (1979) (7)
CAMPATH PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS (2004) (7)
Use of autologous dendritic cells loaded with apoptotic LCL for ex vivo generation of specific CTL from the PBMC of EBV(-) individuals. (2001) (6)
Long-term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short-term tacrolimus immunosuppression (2001) (6)
Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers. (1989) (6)
Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. (1997) (6)
Role of HLA in intragraft cellular immunity in human liver transplantation. (1988) (6)
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. (1999) (6)
Propagation of lymphocytes from human heart transplant biopsies: methodologic considerations. (1988) (6)
Presence of CD4, CD8 double-negative and T-cell receptor-gamma-delta-positive T cells in lymphocyte cultures propagated from coronary arteries from heart transplant patients with graft coronary disease. (1992) (6)
Complement-binding anti-HLA antibodies and kidney transplantation. (2014) (6)
Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II. (2022) (6)
The big picture: A case report of antibody mediated rejection and treatment after lung transplantation illustrating the need to correlate laboratory findings with clinical status. (2013) (6)
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. (1997) (5)
Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis (2018) (5)
In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols. (1989) (5)
Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients. (1998) (5)
Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation. (2011) (5)
Immunomonitoring after human limb allotransplantation. (1998) (5)
Competitive RT-PCR for granzyme-B, IL-15 and rantes for molecular diagnosis of lung allograft rejection (1999) (5)
Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. (1991) (5)
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. (1996) (5)
Human bone marrow obtained from vertebral bodies: cell isolation, phenotyping, progenitor assay, and transplantation. (1994) (5)
Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones (2004) (5)
Oral presentation Abstract session 11Micro-chimerism is associated with a lower incidence of chronic rejection after lung transplantation (1994) (5)
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. (1993) (5)
333: Impact of Inosine 5’-Monophosphate Dehydrogenase 1,2 and Multidrug Resistance Protein 2 Genetic Polymorphisms on Mycophenolate Mofetil Related Adverse Events in Pediatric Heart Transplant Patients (2008) (5)
A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients (2004) (5)
Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation. (2022) (5)
Precision transplant pathology. (2020) (5)
Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection (2017) (4)
Approaching the sensitized lung patient: risk assessment for donor acceptance (2021) (4)
Peripheral lymphocyte markers as surrogate measures of immunosuppression and post-transplant clinical states (2004) (4)
A Three Center Study Reveals New Insights into the Impact of Non-HLA Antibodies on the Acute Rejection Process in Lung Transplantation (2015) (4)
Chronic antibody‐mediated rejection: new diagnostic tools – clinical significance of C4d deposition and improved detection and characterization of human leucocyte antigen antibodies (2014) (4)
On-Demand Immunoglobulin-G Replacement Is Not Associated with Benefits in Lung Transplant Recipients with Hypogammaglobulinemia (2016) (4)
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. (2001) (4)
Definition of MC1, a Novel HLA Determinant Associated with DR1 and DR4 (1984) (4)
MIXED CHIMERISM AFTER TRANSPLANTATION: MECHANISM OR MARKER OF SPECIFIC TOLERANCE? (1993) (4)
The HLA Class II Allele DRB 1 * 1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis (2011) (4)
Successful engraftment following unrelated donor transplant in an alloimmunized patient with Kostmann syndrome (2005) (4)
“Tolerance” assays: the physician's guide to safe weaning of immunosuppression? (2006) (4)
Infectious complications at six months in lung transplant recipients undergoing pretransplant T-cell depletion (2004) (4)
Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients (1997) (4)
DR5: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop (1989) (4)
1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection. (2010) (4)
Isolated vascular “v” lesions in liver allografts: How to approach this unusual finding (2018) (4)
18: Survival in allosensitized children after listing for heart transplantation (2006) (4)
Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. (2012) (4)
Mucosal Plasma Cell Barrier Disruption During Intestine Transplant Rejection (2012) (4)
Carfilzomib for Refractory Antibody Mediated Rejection and Allosensitization in Heart Transplantation (2014) (4)
Cytochrome P4503A5 and TNF-a genotypes are associated with tacrolimus dosing in pediatric heart transplant patients (2002) (4)
Life in the allogeneic environment after lung transplantation (2007) (3)
Hospital readmission following pediatric heart transplantation (2019) (3)
Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis. (2018) (3)
Role of anti-HLA antibodies in allograft rejection (2007) (3)
Definition of HLA-DQ polymorphisms by RFLP and in serological and cellular assays. (1987) (3)
Bortezomib rescue in refractory acute humoral rejection--report of a case. (2009) (3)
DR2: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop (1989) (3)
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation (2021) (3)
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. (1997) (3)
Why does combined liver and kidney transplantation confer an immunologic benefit to a kidney? (2010) (3)
Inhibition of lymphoproliferation by middle ear effusion in experimental otitis media. (1992) (3)
IL-2-augmented primed-lymphocyte test responses of lymphocytes cultured from endomyocardial biopsies from heart transplant patients. (1992) (3)
Operationally Tolerant Pediatric Liver Transplant Recipients Exhibit Features of Immune Activation and Exhaustion.: Abstract# 2960 (2014) (3)
De novo anti-HLA antibodies have the highest incidence in the first year after transplantation (2003) (3)
Antibody Mediated Rejection of the Lung: An ISHLT Consensus Report (2016) (3)
Therapeutic Immunosuppression (2001) (3)
The Immunosuppressive Activity of the Aldehydic Transformation of Cyclosporine on Alloreactive T‐Cells (1991) (3)
Rescue Alemtuzumab for Refractory Acute Cellular Rejection and Bronchiolitis Obliterans Syndrome After Lung Transplantation at a Single High-Volume Center (2015) (3)
IMMUNOLOGIC ASSAYS IN PATIENTS SUCCESSFULLY WITHDRAWN FROM IMMUNOSUPPRESSION (IS) AFTER LIVER TRANSPLANTATION (LTX) (2004) (2)
Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. (1995) (2)
QUANTITATION OF IMMUNOSUPPRESSION BY FK506 USING FLOW CYTOMETRIC ANALYSIS OF IL‐2 AND INF‐&ggr; INHIBITION IN PERIPHERAL BLOOD T CELLS.: Abstract# 1081 (2000) (2)
29-OR: VALIDATION OF THE LUMINEX PLATFORM TO DETECT HLA ANTIBODIES: EFFECT OF STANDARDIZING OPERATION PROCEDURES ON TEST VARIABILITY BY CTOT CORE LABORATORIES (2012) (2)
ALEMTUZUMAB PRECONDITIONING AND TACROLIMUS MONOTHERAPY IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS. (2006) (2)
Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation (2018) (2)
Differences in HLA-D region antigen expression on alloreactive T lymphocyte clones (1982) (2)
Impact of various infectious syndromes on the immune function profile in lung transplant recipients (2007) (2)
93-P Analysis of HLA antibody titer and C1q binding capability in Privigen and Carimune IVIG preparations (2011) (2)
BC1, a new HLA-D region determinant detected by serological and cellular assays (1982) (2)
Therapeutic Human IgG Preparations Contain Mixture of HLA Antibodies to Native HLA Antigens and Cryptic Epitopes With Little Clinical Significance (2018) (2)
Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506. (1991) (2)
LBP11: THE TEST OF TIME. A MULTICENTER EVALUATION OF THE RAPID OPTIMIZED SINGLE ANTIGEN BEAD (ROB) PROTOCOL FOR LABSCREEN (2015) (2)
Kidney/Bone Marrow Transplantation. (1996) (2)
Pediatric liver transplant recipients with operational tolerance exhibit features of immune activation and exhaustion (TRAN3P.869) (2014) (2)
47-P C1q binding donor specific HLA antibody monitoring by luminex single antigen assay is useful in predicting clinical events (2011) (2)
Indirect alloresponses are more pronounced in non-rejecting lung than heart allografts. (2001) (2)
Successful Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors (2017) (2)
Gene Polymorphisms and Pharmacogenomics (2009) (2)
Combined bone marrow and solid organ transplantation with alemtuzumab induction (2003) (2)
Human leukocyte antigen antibodies in liver retransplantation (2010) (2)
Increased Frequency of Class II HLA-DQ Donor-Specific Antibodies Is Associated with Mixed Cellular and Humoral Rejection in Lung Transplantation (2013) (2)
Immune response of young children using ATP‐based Cylex® assay: A brief report (2010) (2)
Autoimmunity, alloimmunity, and chronic liver allograft injury (2012) (2)
Results of a tolerance-enhancing protocol in human lung transplantation (2004) (2)
Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics. (2001) (2)
BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA USING A PHENOTYPICALLY HLA‐IDENTICAL, SBCOMPATIBLE UNRELATED DONOR (1983) (2)
(182) – Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year After Pediatric Heart Transplantation (2017) (1)
ELEVATED HLA-G AND ILT4 EXPRESSION ON CIRCULATING DENDRITIC CELL SUBSETS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS SUCCESSFULLY WEANED OFF IMMUNOSUPPRESSION.: 3095 (2010) (1)
IMMUNOMONITORING IN ALLOGRAFT RECIPIENTS TREATED WITH A TOLERANCE-ENHANCING IMMUNOSUPPRESSIVE REGIMEN (2004) (1)
Bone marrow transplantation of a patient with aplastic anemia from a HLA-identical unrelated donor (1982) (1)
THYMOGLOBULIN PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS: AN UPDATE (2004) (1)
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. (1990) (1)
Two types of CMV-specific memory responses in lung transplant recipients. (1999) (1)
Intragraft cytokine profile during human lung allograft rejection (1992) (1)
Cellular Detection of Human Class II MHC Antigens by Alloreactive T Cell Clones (1986) (1)
Characterizaton of Graft Infiltrating Lymphocytes Involved in Cardiac Transplant Rejection (1994) (1)
Mechanisms of graft rejection and adaptation in pediatric liver transplantation (2003) (1)
RAPAMYCIN RESCUE IN PEDIATRIC LIVER RECIPIENTS WITH TACROLIMUS TOXICITY. A PRELIMINARY EFFECT: CONCENTRATION ANALYSIS.: Abstract# 210 Poster Board #‐Session: P57‐I (2000) (1)
Charges and resource utilization for pediatric heart transplantation across a positive virtual and/or cytotoxicity crossmatch (2018) (1)
DRw6: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop (1989) (1)
DONOR SPECIFIC HUMAN LEUKOCYTE ANTIGEN (HLA) ANTIBODIES AND VISCERAL TRANSPLANTATION: OUTCOME ANALYSIS WITH SPECIAL REFERENCE TO THE LIVER-CONTAINED ALLOGRAFTS: 3143 (2010) (1)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPmNTS1,2 (1995) (1)
Propagation of activated T lymphocytes from endomyocardial biopsy samples of cardiac allografts: Influence of the addition of recombinant interleukin‐4 to the culture environment (2002) (1)
First Experience With the Novel Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation (2014) (1)
Alloreactivity Studies of Lymphocytes in Bronchoalveolar Lavages from Canine Lung Allografts (1989) (1)
Two Types of Cytomegalovirus-Specific Memory Responses: Potential Role of Donor Infected Target Cells in Recruitment of Activated T Cells to the Graft (1998) (1)
Discovery and validation of molecular pathways and diagnostic testing for cardiac rejection in children: a multi-center study (2004) (1)
Long‐term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short‐term tacrolimus immunosuppression (2001) (1)
Local Immunosuppression: The Lung (2001) (1)
IMMUNOSUPPRESSION, EOSINOPHILIA AND ATOPIC DISEASE IN PEDIATRIC HEART TRANSPLANT RECIPIENTS.: Abstract# 639 (2000) (1)
(1263) – Increasing Tacrolimus Time-in-Therapeutic Range Is Associated with Reduced Chronic Lung Allograft Dysfunction (2017) (1)
IL-10 high genotype is protective against acute persistent rejection after lung transplantation (2003) (1)
Inhibitory effects of FK506 in combination with CsA on human lymphocyte alloproliferative responses (1989) (1)
Choosing the Right Patient for Lung Transplantation: Assessment of Histocompatibility and Sensitization Status (2021) (1)
The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients (2022) (1)
Pre-Transplant Opioid Use is Associated with Increased Early Mortality and Readmission after Lung Transplantation (2018) (1)
ranscriptional Signals of T-cell and Corticosteroid-sensitive enes Are Associated With Future Acute Cellular ejection in Cardiac Allografts (2007) (1)
DRw8 and DQw4: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop (1989) (1)
Detection of HLA-DR-, MB-, and MT-associated determinants by alloreactive PLT clones (1982) (1)
279: Gene expression profiles of peripheral blood cells in acute cellular cardiac rejection reflect multiple molecular pathways (2006) (1)
PROPAGATION OF ACTIVATED LYMPHOCYTES UNDER DIFFERING CULTURE CONDITIONS FROM ENDOMYOCARDIAL BIOPSY SAMPLES OF HEART TRANSPLANT RECIPIENTS. • 222 (1996) (1)
CIRCULATING DONOR-SPECIFIC ANTI-HLA ANTIBODY MAY IDENTIFY REJECTION-PRONE PEDIATRIC SMALL BOWEL TRANSPLANT RECIPIENTS: 2859 (2010) (1)
Pre-transplant ELISA analysis for anti-HLA antibodies may identify a group of pediatric patients at high risk for adverse rejection history (2002) (1)
MDR1 EXON26 genotype predicts treatment-resistant rejection in lung transplant patients as assessed by logistic regression analysis (2003) (1)
391 High Titer Donor Specific HLA Antibody Is Complement Binding and Associated with Risk of AMR in Heart Transplant Recipients (2012) (1)
Propagation of lymphocytes infiltrating human liver allografts: correlation with histologic diagnosis of rejection (1988) (1)
Correlation Between PLT and CML Specificity of Alloreactive T Cell Clones (1984) (1)
Mitogen responses and T4/T8 ratios in asymptomatic hemophiliac patients (1985) (1)
Evaluation of the Cellular Immune Response in Transplantation (2006) (1)
Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients (2005) (1)
685 Does the Determination of Complement Binding Add to the Clinical Utility of Donor Specific Antibodies Detected by Luminex (2011) (1)
Donor-specific reactivity and Th1 cytokines--implications for immunologic monitoring. (2009) (1)
Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. (1993) (1)
Campath preconditioning followed by low maintenance immunosuppression in lung transplant recipients (2005) (1)
51-P: Low T cell responses correlate with infection in pancreas transplantation: Case report for monitoring post transplant lymphoproliferative disorder (PTLD) using ImmuKnow™ assay by Cylex (2006) (1)
Significant Reduction of Donor Specific Antibodies in Heart Transplant Recipients Treated with Proteasome Inhibitors for Antibody Mediated Rejection (2022) (1)
ADJUVANT DONOR BONE MARROW INFUSION IN ORGAN TRANSPLANT RECIPIENTS IS ASSOCIATED WITH REDUCED INCIDENCE OF ACUTE AND CHRONIC REJECTION (1999) (1)
THE IMPACT OF T CELL DEPLETION ON IMMUNE RECOVERY IN LUNG TRANSPLANT RECIPIENTS (2004) (1)
OUTCOMES FOLLOWING PRETRANSPLANT T-CELL DEPLETION WITH THYMOGLOBULIN OR CAMPATH IN HUMAN LUNG TRANSPLANTATION (2004) (1)
Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. (1997) (1)
The Timeline of DSA after Cardiac Transplantation (2016) (0)
47-OR: Repeat Mismatching for HLA-DQ Epitopes Increases Rejection of Lung Retransplants (2010) (0)
OR38: CARFIZOMIB FOR REFRACTORY ANTIBODY MEDIATED REJECTION IN LUNG TRANSPLANTATION THE IMPACT ON DSA (2014) (0)
Association between TNF and TGF gene polymorphisms in infants and family history of allergic rhinitis and asthma (2004) (0)
FK506 sensitivity profiles of in vitro activated T cells from organ transplant recipients (1994) (0)
Prevalence and Treatment Responsiveness of Lung Transplant Recipients with Post Transplant Lymphoproliferative Disease (2018) (0)
421: Effect of induction therapy on the peripheral blood genomic signature in the LARGO lung transplant study (2007) (0)
139 Association between Renal Function and Genetic Polymorphisms in Pediatric Heart Transplant Recipients (2012) (0)
Alterations in Peripheral Blood Follicular Helper T Cell (TFH) Subsets and TREG in Kidney Transplant Recipients With DSA.: Abstract# 2219 (2014) (0)
Measuring the impact of infection on T cell immunity in lung transplant recipients treated with a T cell depletion protocol (2005) (0)
( t 11 0 r FK-S 06 Enhances Cyclosporine Uptake by Peripheral Blood Lymphocytes (2010) (0)
C1q‐Binding DSA Induce Distinct Molecular Phenotypes in Kidney Transplant Biopsies.: Abstract# 2864 (2014) (0)
(482) - Treatment of Antibody Mediated Rejection of the Lung Allograft with Carfilzomib-Based Therapy (2017) (0)
Indirect allorecognition in quiescent pediatric and adult thoracic allografts. (1999) (0)
REVERSAL OF GRAFTVERSUSHOST GRAFTVERSUSHOST GRAFTVERSUSHOST VERSUSHOST VERSUSHOST DISEASE WITH INFUSION OF AUTOLOGOUS BONE MARROW (2010) (0)
DYNAMICS AND CLINICAL SIGNIFICANCE OF ANTI-HLA ALLOANTIBODIES IN SOLID ORGAN TRANSPLANTATION (2004) (0)
351: Role of Cylex® assay in monitoring cytomegalovirus (CMV) infection or disease in lung transplant recipients (2006) (0)
8.5-01 Donor specific proliferative and cytotoxic responses of lymphocyte cultures propagated from endomyocardial biopsies and peripheral blood of heart transplant recipients (1989) (0)
Post-Transplant Complement-Binding Donor-Specific Anti-HLA Antibodies Are Strong Predictors of Kidney Allograft Outcome: 900 (2012) (0)
DC1-Based Protocols for Adoptive Immunotherapy for PTLD Boost Type-1 Anti-EBV CD8+ T Cell Responses in Solid Organ Tranplant Patients (2004) (0)
Measurement of immune function in lung transplant recipients using the Cylex ImmuKnow Assay (2005) (0)
Loss of anti-AT1R reactivity in ELISA post-adsorption - False reactivity or interference in the assay? (2023) (0)
84-P Looking longitudinally: Serial cylex immuknow testing and patient history better demonstrate clinical event in renal allograft recipients (2011) (0)
CONCURRENT SESSION 44: HLA ANTIBODIES IMPACT POST TRANSPLANTATION (2006) (0)
MO942: Regulatory T and B Cell Responses are Equally Compromised During Antibody-Mediated Rejection of Kidney Allografts (2022) (0)
315: The Impact of HLA-G Polymorphism on Acute Rejection in Pediatric Heart Transplant Recipients (2010) (0)
248: HLA-Specific Antibody Strength and HLA Haplotype Frequency as Predictors for Responsiveness to Desensitization Protocols and Transplantability Rate in Heart Transplant Candidates (2009) (0)
600 TNFα Polymorphisms and susceptibility to illness in adults experimentally infected with influenza a (FLU) virus (2000) (0)
Novel Tools for Immune Quiescence Monitoring in Kidney Transplantation.: Abstract# A11 (2014) (0)
Role of HLA Class II-Specific Alloreactive T Cells in Biliary Epithelium Injury Associated with Liver Transplant Rejection (1989) (0)
35-OR: HIGH TITER HLA ANTIBODY IS C1q BINDING AND ASSOCIATED WITH INCREASED RISK OF ANTIBODY MEDIATED REJECTION IN HEART ALLOGRAFT RECIPIENTS (2012) (0)
Use of Alerntuzumab and Tacrolirnus Monotherapy for Cadaveric Liver Transplantation : With Particular Reference to Hepatitis C Virus (2010) (0)
455: Applications of a Uniform Strategy of Virtual Cross Match in Heart Transplantation (2010) (0)
HLA Antibody Titer and C1Q Reactivity Reflect Response to Desensitization and Facilitate Donor Selection (2019) (0)
A COMBINATION OF INTRATHYMIC AND PORTAL VENOUS INJECTION OF DONOR BONE MARROW CELLS PRODUCES LONG-TERM SURVIVAL OF CARDIAC ALLOGRAFTS IN HIGH RESPONDER RAT STRAINS. (1999) (0)
Carfilzomib-Based Therapy Produces Favorable Outcomes for Antibody Mediated Rejection of the Lung Allograft (2016) (0)
ALEMTUZUMAB INDUCTION HAS LONG-TERM EFFECT ON T CELL MEMORY AND T REGULATORY CELL (TREG) SUBSETS IN KIDNEY TRANSPLANT RECIPIENTS: 2950 (2010) (0)
Impact of Right Ventricular Function and Pulmonary Hypertension Therapy on Graft Dysfunction and Death in Lung Transplant Recipients (2018) (0)
Lymphocyte growth from endomyocardial biopsies in pediatric heart allografts (1991) (0)
Carfilzomib for Heart Transplant Desensitization. (2020) (0)
CONCURRENT SESSION 35: PTLD AND TRANSPLANT ASSOCIATED MALIGNANCY: BASIC INVESTIGATIONS 206 World Transplant Congress 2006 (PI-3K) and hypoxia-inducible factor-1α (HIF-1α) activity, two key mediators of gastric cancer growth and angiogenesis, we investigated mTOR activation in human gastric adenocarc (2006) (0)
10: EDTA-Treated Serum Unmasks Complement-Mediated Prozone Inhibition (2015) (0)
HLA-G II GENOTYPE AND LOW LEVELS OF SOLUBLE HLA-G POST-TRANSPLANT ARE ASSOCIATED WITH FIRST YEAR REJECTION POST PEDIATRIC HEART TRANSPLANTATION.: 881 (2010) (0)
NOVEL GENE POLYMORPHISMS IN THE IMPDH2 GENE MAY ACCOUNT FOR NEUTROPENIA AND OTHER SIDE EFFECTS IN PATIENTS TREATED WITH MYCOPHENOLIC ACID (MPA). (2006) (0)
451: Epidemiology of late bacterial pneumonia in a prospective cohort of lung transplant recipients (LTRs) (2007) (0)
Cross Validation of Luminex Platforms from Two Vendors to Detect and Quantify HLA Antibodies Using Single Antigen Assay Results from 7 CTOT Core Laboratories: 1969 (2012) (0)
DECREASED IN VIVO APOPTOSIS IN GRAFT INFILTRATING T‐CELLS OBTAINED FROM LUNG ALLOGRAFTS.: Abstract# 113 (2000) (0)
Analysis of the function and state of activation of donor specific lymphocytes in thoracic transplant recipients (1991) (0)
Influence of pre and post-transplant ELISA-detected anti-HLA antibodies on pediatric heart transplant outcome (2004) (0)
PREFORMED XENOREACTIVE ANTIBODIES TO PIG NONGAL ANTIGENS IN HEALTHY AND ALLOSENSITIZED HUMANS (2006) (0)
418: Mycophenolate mofetil is associated with decreased de novo anti-HLA alloantibodies in the first year after lung transplantation (2007) (0)
Recovery of T cell memory cells in lung transplant recipients treated with T cell depletion therapies (2004) (0)
Mycophenolate-Based Immunosuppressive Regimens Are Associated with a Mortality Benefit in Lung Transplantation Recipients at a Single High-Volume Center (2016) (0)
Complement Binding Donor Specific Antibody: Detection, Inhibition and Clinical Relevance in Sensitized Heart Transplant Recipients: 678 (2012) (0)
Hlamatchmaker and the recognition of alloepitopes on HLA molecules (2004) (0)
Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal. (2022) (0)
Flow cytometric analysis of activation actigens on human T-cell subsets: Influence of the immunosuppressive macrolide FK-506 and nucleotide synthetase inhibitors (1991) (0)
Subject Index Vol. 42, 1999 (2000) (0)
Development of an HLAmatchmaker-based computer database for managing highly sensitized patients in a clinical setting (2002) (0)
Enhanced donor antigen presentation by B-cells predicts acute cellular rejection and late outcomes after transplantation (2022) (0)
29-P : IN VITRO INHIBITION OF COMPLEMENT ACTIVATING HLA ANTIBODY BY C1 ESTERASE INHIBITOR (Berinert®) (2013) (0)
11-OR: HLA-G II Genotype and Low Levels of sHLA-G Post-Tx are Associated With First Year Rejection in Pediatric Heart Transplantation (2010) (0)
OR12 Complement-binding donor-specific anti-HLA antibodies predict the response to complement-targeting therapy: A multicenter international study (2017) (0)
OR50 Complement-binding donor-specific anti-HLA antibodies induce a specific histo-molecular kidney allograft rejection phenotype (2017) (0)
10.1-02 Propagation and characterization of lymphocytes infiltrating livers of patients with hepatic autoimmune diseases (1989) (0)
107-P: Immune cell function in patients with BK virus (BKV) activation and rejection-like infiltrate (2009) (0)
39-OR: CYTOKINE AND CHEMOKINE GENE POLYMORPHISMS IMPACT ON CMV INFECTION IN LUNG TRANSPLANT RECIPIENTS (2012) (0)
Pro-Inflammatory Cytokine Modulation of the IL-33 Receptor During Pediatric Allograft Rejection.: Abstract# A24 (2014) (0)
Functional analysis of lung biopsy and bronchoalveolar lavage (BAL) derived lymphocytes from heart-lung transplant recipients (1988) (0)
Increased granzyme B and rantes mRNA in rejecting lung allografts- quantitative analysis by Taqman (2002) (0)
Pre-Treatment High Titer DSA Is Associated with Non-Responsiveness to Carfilzomib-Based AMR Therapy in Lung Transplant Recipients (2016) (0)
18-P: HLA-specific antibody strength determined by solid-phase assays correlates with donor-specific crossmatches and transplantability rate in sensitized heart candidates (2009) (0)
217.2: A Multi-institutional Study of Factors Determining Cardiac Allograft Function in Children at 3 Years Post-transplant: Absence of Impact of Donor Specific Antibodies (2022) (0)
THE EFFECT OF CYTOKINE GENE POLYMORPHISM ON PEDIATRIC HEART ALLOGRAFT OUTCOME.: Abstract# 35 (2000) (0)
532: Genetic Polymorphisms Impact the Risk of Infection in Pediatric Heart Transplantation – A Multi-Center Study (2009) (0)
Donor-specific anti-HLA alloantibodies are associated with subendothelial C4d deposition and chronic lung allograft dysfunction (2005) (0)
T cell immunity in lung transplant recipients (2005) (0)
46-P: Frequency of de novo anti-HLA alloantibody detection in four lung transplantation therapeutic protocols (2007) (0)
HLA mismatching increases the incidence of BK viral nephritis after kidney transplantation (2003) (0)
Cellular immunotherapy for post-transplant lympho-proliferative disease (PTLD) using recipeint's lymphokine activated killer (LAK) cells generated Ex-Vivo (1996) (0)
98-P: Immunosuppression minimization in multivisceral transplant recipients: The impact on global T cell immunity and humoral activity (2009) (0)
Relationship Between Anti-HLA Antibodies and Coronary Allograft Vasculopathy after Heart Transplantation (2014) (0)
OR28 Are all donor-specific hla antibodies equally associated with increased risk of chronic lung allograft dysfunction? (2019) (0)
43-W: Post-pregnancy developed alloreactive B cells in a seventy years old lung transplant patient (2008) (0)
The Role of Dynamic DNA Methylation in Liver Transplant Rejection in Children (2022) (0)
Cord blood lymphocytes show higher ATP production compared to peripheral blood lymphocytes from children and adults (2009) (0)
Association between MRSA Colonization and Chronic Lung Allograft Dysfunction in Lung Transplantation for Cystic Fibrosis. (2020) (0)
Renal transplantation in baboons under FK 506. (1989) (0)
The HLA Class II Allele Allele DRB 1 * 15 is over-represented in patients with Idiopathic Pulmonary Fibrosis (2017) (0)
Early recovery of T cell immunity in pancreas transplant recipients treated with Campath-1H (2005) (0)
Phenotype changes on peripheral blood lymphocytes in liver transplant recipients immunosuppressed by FK 506 (1992) (0)
HLA-specific antibodies are associated with lymphocytic bronchiolitis and decreased pulmonary function after lung transplantation (2005) (0)
Tacrolimus Immunosuppressive Regimens Are Associated with a Mortality Benefit in Lung Transplantation Recipients at a High-Volume Single Center (2016) (0)
Sensitivity of Activated Hwnan Lymphocytes to Cyclosporine and Its Metabolites (2010) (0)
3-P: Determination of allosensitization by multiple assays and associations within first year rejection (2009) (0)
40-P: The sponge effect of allograft removal on the detection of donor specific anti-HLA antibodies in lung re-transplantation (2006) (0)
Presence of primed CMV-specific lymphocytes in bronchoalveolar lavage of lung transplant recipients; correlation with CMV infection (1991) (0)
De novo HLA antibodies and lymphocytic bronchiolitis are significantly correlated with bronchiolitis obliterans syndrome in lung transplantation (2004) (0)
A NOVEL APPROACH TO GENERATE (EX VIVO) EBV-SPECIFIC CYTOTOXIC T CELLS FROM A NAÏVE IMMUNOCOMPETENT EBV-NEGATIVE INDIVIDUAL (1999) (0)
P149 Successful pediatric heart transplant across low titer-C1q-negative DSA and a discordant flow/CDC crossmatch results after bortezomib therapy (2016) (0)
87 The Impact of Pre-Formed Donor-Specific HLA Antibodies on Early Clinical Outcomes in Lung Transplant Recipients (2011) (0)
Impact of pre-transplant thymoglobulin therapy on immune responses in lung transplant recipients (2003) (0)
GENESIS AND DIAGNOSIS OF BRONCHIOLITIS OBLITERANS POST-LUNG TRANSPLANTATION: LESSONS LEARNED FROM BRONCHOALVEOLAR LAVAGE (1996) (0)
P012 Human IVIG preparations contain antibody to native and denatured HLA (2016) (0)
Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients. (2019) (0)
Poster session63-P The relevance of pre-transplant soluble HLA-G levels and/or donor specific HLA antibodies on renal allograft survival (2011) (0)
Alloantibody Reduction in Pediatric Heart Transplant Recipients (2019) (0)
TYPE-1 POLARIZATION OF CD8+ T CELL RESPONSES AGAINST EBV ANTIGENS IS PRESERVED IN IMMUNOSUPPRESSED STABLE SOLID ORGAN TRANSPLANT RECIPIENTS (2004) (0)
40-OR: The combination high VEGF/high IL-6 and low IL-10 gene polymorphism impact the risk of acute rejection in pediatric heart transplantation – a multicenter study (2007) (0)
GF-J 31 pretreatment impairs the tllostimulatory function of human bone narrow-derived antigen-presenting cells or both naive and primed T cells (2010) (0)
DISTINCT PATTERNS OF SOLUBLE HLA CLASS I AND FREE HEAVY CHAIN RELEASE IN LUNG TRANSPLANT PATIENTS DURING REJECTION VS CMV INFECTION (1999) (0)
223: Use of an Immune Monitoring Assay To Distinguish between Fungal Colonization and Fungal Disease in Lung Transplant Recipients (2008) (0)
The effects of inhaled cyclosporine A (CYA) in lung transplant recipients: correlation between histology and intragraft cytokine gene expression (1994) (0)
Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with epstein-barr virus associated post-transplant lymphoproliferative disease (1994) (0)
Advanced Lung Disease and Lung Transplantation 2-1-2011 The HLA Class II Allele Allele DRB 1 * 15 is over-represented in patients with Idiopathic Pulmonary Fibrosis (2013) (0)
Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons. (2022) (0)
P001 Changes in anti-HLA antibody complement-binding capacity reflect the efficacy of antibody-mediated rejection therapy and predict kidney allograft survival (2017) (0)
Aha Scientific Statement Antibody-mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management a Scientific Statement from the American Heart Association Endorsed by the International Society for Heart and Lung Transplantation (0)
P053 Pre-treatment DSA titer predicts the effectiveness of carfilzomib-based therapy for antibody mediated rejection in lung transplant recipients (2016) (0)
Functional studies of in vivo committed lymphocytes propagated from organ transplants. (1986) (0)
Sterilization of human small intestine allograft biopsies for later immunologic studies. (1991) (0)
P148 Uncovering antibodies to cryptic epitopes: Use of flow cytometry crossmatch to differentiate between functional and denatured epitopes (2016) (0)
Increased incidence of severe lung allograft acute rejection in patients exhibiting HLA-specific antibodies (2003) (0)
68-P : DONOR-SPECIFIC CLASS II HLA-DQ COMPLEMENT BINDING ANTIBODY IS ASSOCIATED WITH SEVERE REJECTION IN LUNG TRANSPLANTATION (2013) (0)
New Insights in to the Impact of Auto-Antibodies on the Acute Rejection Process in Lung Transplantation (2015) (0)
314: Genotypic Variation and Phenotypic Characterization of Granzyme B Gene Polymorphisms (2008) (0)
Successful Eradication of De Novo C1q-Binding Donor-Specific Antibodies with Rituximab Monotherapy (2021) (0)
184-P: STR chimerism analysis to monitor GVHD in a multivisceral allograft recipient (2008) (0)
Acquisition of HLA antigen expression by alloactivated T lymphocytes: A new regulatory mechanism through ‘allospecific autorecognition’ (1994) (0)
Clinical relevance of hla class I and class II antibodies detected by ELISA in lung transplantation (2002) (0)
Donor-specific hyporeactivity in bone marrow (BM) augmented solid organ transplant recipients. (1995) (0)
Detection of hidden alloreactive cells in heart transplant recipients by augmented PLT assays (1988) (0)
34-P: Clinical and Pathological Significance of Anti-Donor Antibodies in Liver Allograft Recipients (2010) (0)
238: Campath-1H induction and maintenance drug minimization in lung transplantation: One-year outcomes and comparison with triple drug immunosuppression with or without dacluzimab induction (2006) (0)
6-P Spectrum of allosensitization following homograft implantation (2011) (0)
Novel Use of the Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation.: Abstract# C2028 (2014) (0)
Retrospective analysis of monitoring small bowel transplant recipients with the Cylex® ImmuKnow™ Assay (2004) (0)
39-OR: The levels of soluble C4d in bronchoalveolar lavage fluid can discriminate between the presence of infections or antibody-mediated rejection in lung transplanted patients (2006) (0)
Limitations of single HLA antigent Elisa analysis of high PRA SERA (2003) (0)
Relationship of cytokine gene polymorphism to the post-transplant outcomes (2001) (0)
THE NOVEL USE OF AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC LCL FOR EX VIVO GENERATION OF SPECIFIC CTL FROM THE PBMC OF EBV INDIVIDUALS.: Abstract# 629 (2000) (0)
Augmented donor-specific chimerism and immune modulation in solid organ transplant recipients following infusion of unmodified donor bone-marrow. (1996) (0)
66-P: Correlation of immune function monitoring with tapering of Tacrolimus in long-term renal allograft recipients (2007) (0)
Functional differences between cells from MLA colonies grown in soft agar culture (1980) (0)
Effect of Everolimus and CNI Reduction on Rejection, CLAD, and Death in Thoracic Transplant Recipients (2018) (0)
97-P: Detection of serum antibody in renal allografts with focal peritubular capillary C4d deposition (2009) (0)
95-P Increased risk for bronchiolitis obliterans in lung transplant recipients who develop post transplant donor specific HLA antibodies (2011) (0)
Contents, Vol. 62, 1979 (1979) (0)
Transfer of HLA antigens from stimulatory B cells to alloreactive T lymphocytes: a novel mechanism of "allospecific" autoregulation. (1999) (0)
Living renal transplantation across donor-specific antibodies; laboratory perspective (2002) (0)
200: Clinical Experience with the Use of Virtual Crossmatch in Adult Lung Transplantation (2009) (0)
317: Cell Bound Complement Activation Products as Biomarkers of Humoral Rejection in Pediatric Heart Transplantation (2010) (0)
36-P: Phenotypes of acute cellular rejection of lung transplant recipients following induction therapy with T-cell depleting agents (2008) (0)
170-P: Angiotensin II Type 1 Receptor Antibodies in a Case of Hyperacute Renal Allograft Rejection (2010) (0)
C1q-binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment (2018) (0)
31-P: HLA-A and HLA-B amino-acid triplet mismatching is associated with increased frequency of acute rejection in pediatric heart transplantation (2007) (0)
Influence of cytokine and growth factor gene polymorphisms on acute and chronic rejection after pediatric heart transplantation (2003) (0)
280-P: Quality assessment as a management tool in the histocompatibility laboratory (2009) (0)
DIFFERENCES IN SOLUBLE HLA AND &bgr;2M‐FREE HEAVY CHAIN RELEASE DURING CMV INFECTION BETWEEN PATIENTS WITH GOOD VS POOR OUTCOME.: Abstract# 112 (2000) (0)
65-P: MONITORING RENAL ALLOGRAFT RECIPIENTS BY LUMINEX C1q TESTING: ASSOCIATION WITH CLINICAL AND PATHOLOGICAL RESULTS (2012) (0)
Colony growth of T lymphocytes in vitro. Control and regulation of clonal formation. (1979) (0)
60-P: Case report: Monitoring the development of donor-specific anti-HLA antibody as a guide to modulate spacing of tacrolimus monotherapy (2006) (0)
Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation1 (2002) (0)
Alloreactive Lymphocyte Propagation from Endomyocardial Biopsies from Heart Transplant Patients on Different Prophylactic Immunosuppressive Treatment Protocols (1989) (0)
Sequential analysis of cell mediated immunity in small bowel transplant recipients (2002) (0)
Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements. (2023) (0)
Alloreactive Lymphocyte Adherence to Human Arterial Endothelial Cell Monolayers (1989) (0)
Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II (2023) (0)
HLA Antigen Expression in Cardiac Transplant Biopsies: Association with Rejection and Propagation of Infiltrating Alloreactive Lymphocytes (1989) (0)
ASSOCIATION BETWEEN PARAINFLUENZA VIRUS INFECTION AND ACTIVE BROCHIOLITIS OBLITERANS IN LUNG TRANSPLANT RECIPIENTS.: Abstract# 476 Poster Board #‐Session: P116‐II (2000) (0)
ow did a patient who types for HLA-B * 4403 develop antibodies that react with LAB * 4402 ? on Lomago (0)
40-P: Lack of association between immune function and humoral sensitization in renal transplant recipients (2008) (0)
Detection of T-cell memory responses—a new assay applicable for cohorts of immunocompromised individuals (2003) (0)
Immunomonitoring in allograft recipients treated with a T cell depleting protocol and minimum immunosuppression (2004) (0)
Elevated HLA-G Expression On Myeloid Dendritic Cells Correlates With Regulatory T Cell Foxp3 Expression In Operationally Tolerant Pediatric Liver Transplant Recipients (2011) (0)
ABDR and amino acid triplet HLA mismatches are associated with the development of anti-HLA antibodies after renal transplantation (2004) (0)
Transfusion associated graft vs. host disease in an immunocompetent recipient –case report (2005) (0)
QS210. Adipose Derived Stem Cells: A Novel Source of Stem Cell for Bone Marrow Transplant (2008) (0)
Plasma Inflammatory Markers Associated with Bone Resorption and Formation in COPD. (2009) (0)
Repertoire, memory subsets, and function of EBV-specific CD8+T cells in peripheral blood from stable solid organ transplant patients (2003) (0)
Monitoring immune reactivity in bone marrow augmented kidney recipients (1994) (0)
Operational tolerance after intestine re‐transplantation in childhood and immunological correlates. Case report and review (2022) (0)
26-OR: Impact of genetic polymorphisms on rejection with hemodynamic compromise – A multi-institutional study (2008) (0)
FP766RESPONSE TO TREATMENT IN KIDNEY RECIPIENTS WITH ANTIBODY-MEDIATED REJECTION: A DATA-DRIVEN APPROACH (2019) (0)
Effect of Aerosolized Antipseudomonals on Pseudomonas Recurrence and Bronchiolitis Obliterans Syndrome after Lung Transplantation (2016) (0)
Post-transplant evaluation of anti-HLA antibody in small bowel transplant recipients following T cell depletion protocols – case report (2005) (0)
Pretransplant serum sCD30: Impact on graft outcome after kidney transplantation (2005) (0)
Persistently Low Immunereactivity As Determined By PHA-Induced ATP Release Is Associated With Inferior Outcome In Allogeneic Hematopoietic Stem Cell Transplantation (2010) (0)
A clinical trial of intrathymic inoculation of donor bone marrow cells with concomitant pediatric heart transplantation: preliminary observations. (1999) (0)
29 New onset of autoantibodies and hepatic disease in liver transplanted children (2003) (0)
Angiotensin converting enzyme gene polymorphisms in pediatric liver transplant recipients (2004) (0)
Serial in vitro studies in bone marrow augmented liver transplant recipients (1994) (0)
Diagnostic Criteria for Nonviable Pregnancy (2014) (0)
84 The Impact of Donor Specific HLA Antibodies in Lung Transplantation after Induction with Alemtuzumab (2011) (0)
The impact of growth factor gene polymorphism on the development of coronary artery disease and impaired renal function in pediatric heart transplantation (2004) (0)
INCREASED ALLELE FREQUENCIES OF LOW‐PRODUCING IFN‐Y AND HIGH‐PRODUCING IL‐6 IN GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENCY: 161 (2004) (0)
261-P: A case of AMR in a renal transplant patient who exhibited an anamnestic antibody response and the monitoring of treatment efficacy (2009) (0)
592 Utility of Routine C4d Staining in the First Year after Pediatric Heart Transplantation (2012) (0)
Correction (2009) (0)
84 Increased Frequency of Donor Specific HLA Antibody in Lung Transplant Recipients with Acute Cellular Rejection: Spectrum of Alloantibody and the Impact on Histopathology (2012) (0)
432 T-cell anergy and relative sparing of antigen-presenting cells may explain rejection and graft adaptation by regulatory-suppressor cell formation with thymoglobulin in pediatric liver transplantation (2003) (0)
Subendothelial C4d deposition and intragraft B cell infiltrates are associated with high-grade acute rejection in lung transplantation (2005) (0)
Comparison of the biopsy growth assay in heart transplant patients on cyclosporine vs fk506 immunosuppressant (1991) (0)
Subject Index, Vol. 62, 1979 (1979) (0)
Limiting dilution analysis of alloreactive lymphocyte adherence to human arterial endothelial cell monolayers (1988) (0)
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients (1996) (0)
KINETICS OF T CELL MEMORY RECOVERY IN LUNG TRANSPLANT RECIPIENTS TREATED WITH T CELL DEPLETION THERAPIES (2004) (0)
Title Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection (2017) (0)
Prolonged survival of viable human islets in serum free media (1994) (0)
HLA Eplet Mismatch Analysis of a Large Multi-Center Pediatric Heart Transplant Cohort: Not All Transplants are Immunologically Equal (2021) (0)
325: Impact of Campath-1H conditioning on DC subsets in peripheral blood of lung transplant recipients (2006) (0)
Confirmation of ELISA detected de novo antibodies by flow cytometry (2003) (0)
Cytokine gene polymorphism moderate illiness severity in infants with respiatory syncytial virus (RSV) infection (2003) (0)
Impact of pre-transplant T cell depletion combined with tacrolimus monotherapy on the immune responses in lung transplant recipients (2004) (0)
Chronic Lung Allograft Dysfunction is Associated with an Increased Number of Autoantibodies (2023) (0)
43 Heart Transplantation in Sensitized Recipients, the Impact of Pre-Transplant Donor-Specific Antibodies on Clinical Outcome (2011) (0)
CYTOTOXICITY OF LAK CELLS AND EBV-SPECIFIC T CELLS AGAINST LYMPHOBLASTOID EBV-POSITIVE B CELLS: A MODEL FOR CELLULAR THERAPY OF PTLD (1998) (0)
420: The Impact of Repeat HLA Mismatch on Pulmonary Retransplantation (2010) (0)
CMV pathogenesis in lung transplantation. (1995) (0)
linical Implications and Longitudinal Alteration of Peripheral lood Transcriptional Signals Indicative of Future Cardiac llograft Rejection (2008) (0)
BRIEF COMMUNICATIONS EVIDENCE FOR ENGRAFTMENT OF HUMAN BONE MARROW CELLS IN NON-LETHALLY IRRADIATED BABOONS l (0)
In vitro measurement of functional cell-mediated immunity: evidence of increased immunosuppression in longterm transplant recipients (2002) (0)
(1155) - ST266 Improves Oxygenation and Reduces Tissue Injury in an In-Situ Rat Left Lung Ischemia-Reperfusion Model (2017) (0)
Infection profile in lung transplant recipients associated with suppressed T cell reactivity (2006) (0)
ST266 Attenuates Acute Elastase-Induced Lung Emphysema in Mice (2017) (0)
Disparate genetic polymorphism among ethnic groups in pediatric heart transplantation (2006) (0)
Increased Hazard of Chronic Lung Allograft Dysfunction in the Presence of Persistent and Complement Fixing Donor-Specific Antibodies (2019) (0)
Simultaneous infusion of donor bone marrow at the time of whole organ transplantation (1994) (0)
IMMUNE MODULATION IN ORGAN RECIPIENTS BY SINGLE OR MULTIPLE DONOR BONE MARROW INFUSIONS (1998) (0)
Effects of immunosuppressive macrolides and nucleotide synthetase inhibitors on proliferation of lymphoid cells induced via distinct signal transduction pathways (1991) (0)
173-P: RECYCLING ALLOGRAFT KIDNEYS: MONITORING FOR HLA ANTIBODIES (2012) (0)
Cytokine Networks in Transplant Rejection. Preface. (2008) (0)
CTLA4Ig REDUCES THE DOSE OF RADIATION REQUIRED TO ACHIEVE MIXED HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC TRANSPLANTATION TOLERANCE IN RATS (1998) (0)
Early Phase Circulating Donor-Derived Cell-Free DNA in Patients after Lung Transplantation (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Adriana Zeevi?

Adriana Zeevi is affiliated with the following schools:

Adriana Zeevi's Academic­Influence.com Rankings

Adriana Zeevi's Degrees

Similar Degrees You Can Earn

Why Is Adriana Zeevi Influential?

Adriana Zeevi's Published Works

Published Works

What Schools Are Affiliated With Adriana Zeevi?

Adriana Zeevi's AcademicInfluence.com Rankings